Tratamiento de la depresión comórbida después de un síndrome coronario agudometaanálisis de ensayos controlados aleatorizados

  1. Ana M. Bueno
  2. Miguel A. Simón
Revista:
Psicología conductual = behavioral psychology: Revista internacional de psicología clínica y de la salud

ISSN: 1132-9483

Año de publicación: 2024

Volumen: 32

Número: 1

Páginas: 89-109

Tipo: Artículo

DIALNET GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: Psicología conductual = behavioral psychology: Revista internacional de psicología clínica y de la salud

Resumen

men La depresión postsíndrome coronario agudo (post-SCA) aumenta el riesgo cardíaco; sin embargo, la eficacia de las terapias antidepresivas para su tratamiento no está suficientemente demostrada. Nuestro objetivo es metaanalizar ensayos controlados con muestras homogéneas que permitan explicar la inconsistencia de los resultados obtenidos hasta el momento. Tras revisar 1525 artículos, dos revisores independientes identificaron 7 estudios que cumplían criterios muy restrictivos para asegurar la homogeneidad de las muestras. Los resultados indicaron que los pacientes tratados con intervenciones de eficacia demostrada para la depresión, reducen sus niveles de trastorno depresivo significativamente más que los sujetos sin este tratamiento, y que existen diferencias significativas en el número de pacientes que reducen los síntomas depresivos de forma clínicamente relevante. Además, se observaron menos eventos cardiovasculares adversos durante el tratamiento, aunque esta diferencia fue mínimamente significativa y no se mantuvo tras el seguimiento. Estos resultados sugieren que la inconsistencia de los datos actualmente disponibles podría deberse a dificultades metodológicas que evidencian la necesidad de nuevas investigaciones que aclaren el efecto del tratamiento de la depresión sobre el pronóstico post-SCA.

Referencias bibliográficas

  • Amin, A. A., Jones, A. M., Nugent, K., Rumsfeld, J. S. y Spertus, J. A. (2006). The prevalence of unrecognized depression in patients with acute coronary syndrome. American Heart Journal, 152(5), 928-934.
  • Baumeister, H., Hutter, N. y Bengel, J. (2011). Psychological and pharmacological interventions for depression in patients with coronary artery disease. Cochrane Database of Systematic Reviews, 9, CD008012.
  • Beck, A. T. y Steer, R. A. (1993). Manual for the Beck Depression Inventory. Psychological Corporation.
  • Carney, R. M., Blumenthal, J. A., Freedland, K. E., Youngblood, M., Veith, R. C., Burg, M. M., Cornell, C., Saab, P. G., Kaufmann, P. G., Czajkowski, S. M., Jaffe, A. S. y ENRICHD investigators (2004). Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosomatic Medicine, 66(4), 466-474.
  • Carney, R. M. y Freedland, K. E. (2008). Depression in patients with coronary heart disease. The American Journal of Medicine, 121(11), S20-S27.
  • Carney, R. M. y Freedland, K. E. (2012a). Are somatic symptoms of depression better predictors of cardiac events than cognitive symptoms in coronary heart disease? Psychosomatic Medicine, 74(1), 33-38.
  • Carney, R. M. y Freedland, K. E. (2012b). Is there a high-risk subtype of depression in patients with coronary heart disease? Current Psychiatry Reports, 14, 1-7.
  • Carney, R. M. y Freedland, K. E. (2017). Depression and coronary heart disease. Nature Reviews Cardiology, 14(3), 145-155.
  • Celano, C. M. y Huffman, J. C. (2011). Depression and cardiac disease: a review. Cardiology in Review, 19(3), 130-142.
  • Davidson, K. W., Rieckmann, N., Clemow, L., Schwartz, J. E., Shimbo, D., Medina, V., Albanese, G., Kronish, I., Hegel, M. y Burg, M. M. (2010). Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial. Archives of Internal Medicine, 170(7), 600-608.
  • Dickens, C., Cherrington, A., Adeyemi, I., Roughley, K., Bower, P., Garrett, C., Bundy, C. y Coventry, P. (2013). Characteristics of psychological interventions that improve depression in people with coronary heart disease: a systematic review and metaregression. Psychosomatic Medicine, 75(2), 211-221.
  • Dowlati, Y., Herrmann, N., Swardfager, W. L., Reim, E. K. y Lanctot, K. L. (2010). Efficacy and tolerability of antidepressants for treatment of depression in coronary artery disease: a meta-analysis. The Canadian Journal of Psychiatry, 55(2), 91-99.
  • Doyle, F., McGee, H., Conroy, R., Conradi, H. J., Meijer, A., Steeds, R., Sato, H., Stewart. D. E., Parakh, K., Carney, R., Freedland, K., Anselmino, M., Pelletier, R., Bos, E. y de Jonge, P. (2015). Systematic review and individual patient data meta-analysis of sex differences in depression and prognosis in persons with myocardial infarction: a MINDMAPS study. Psychosomatic Medicine, 77(4), 419-428.
  • ENRICHD Investigators (2003). Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA, 289(23), 3106- 3116.
  • Fernandes, N., Prada, L., Rosa, M. M., Ferreira, J. J., Costa, J., Pinto, F. J. y Caldeira, D. (2021). The impact of SSRIs on mortality and cardiovascular events in patients with coronary artery disease and depression: systematic review and meta-analysis. Clinical Research in Cardiology, 110, 183-193.
  • Glassman, A. H., Bigger, J. T. y Gaffney, M. (2009). Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants. Archives of General Psychiatry, 66(9), 1022-1029.
  • Glassman, A. H., O'Connor, C. M., Califf, R. M., Swedberg, K., Schwartz, P., Bigger Jr, J. T., Krishnan, R. R., van Zyl, L. T., Swenson, J. R., Finkel, M. S., Landau, C., Shapiro, P. A., Pepine, C. J., Mardekian, J., Harrison, W. M. y Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) group (2002). Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA, 288(6), 701-709.
  • Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23(1), 56-62.
  • Higgins, J. P., Altman, D. G., Gøtzsche, P. C., Jüni, P., Moher, D., Oxman, A. D., Savović, J., Schulz, K. F., Weeks, L. y Sterne, J. A. (2011). The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. British Medical Journal, 343, d5928.
  • Higgins, J. P. y Thompson, S. G. (2002). Quantifying heterogeneity in a meta‐analysis. Statistics in Medicine, 21(11), 1539-1558.
  • Honig, A., Kuyper, A. M., Schene, A. H., van Melle, J. P., de Jonge, P., Tulner, D. M., Schins, A., Crijns, H. J., Kuijpers, P. M., Vossen, H., Lousberg, R. y Ormel, J. (2007). Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine. Psychosomatic Medicine, 69(7), 606-613.
  • Kang, H. J., Stewart, R., Bae, K. Y., Kim, S. W., Shin, I. S., Hong, Y. J., Ahn, Y., Jeong, M. H., Yoon, J. S. y Kim, J. M. (2015). Predictors of depressive disorder following acute coronary syndrome: results from K-DEPACS and EsDEPACS. Journal of Affective Disorders, 181, 1-8.
  • Kim, J. M., Bae, K. Y., Stewart, R., Jung, B. O., Kang, H. J., Shin, I. S., Hong, Y. J., Kim, J. H., Shin, H. Y., Kang, G., Ahn, Y., Kim, J. K. Jeong, M. H. y Yoon, J. S. (2015). Escitalopram treatment for depressive disorder following acute coronary syndrome: a 24-week double-blind, placebo-controlled trial. The Journal of Clinical Psychiatry, 76(1), 62-68.
  • Kim, J. M., Stewart, R., Lee, Y. S., Lee, H. J., Kim, M. C., Kim, J. W., Kang, H. J., Bae, K. Y., Kim, S. W., Shin, I. S., Hong, Y. J., Kim, J. H., Ahn, Y., Jeong, M. H. y Yoon, J. S. (2018). Effect of escitalopram vs placebo treatment for depression on long-term cardiac outcomes in patients with acute coronary syndrome: a randomized clinical trial. JAMA, 320(4), 350-357.
  • Kroenke, K., Spitzer, R. L. y Williams, J. B. (2001). The PHQ‐9: validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606-613.
  • Kronish, I. M., Rieckmann, N., Schwartz, J. E., Schwartz, D. R. y Davidson, K. W. (2009). Is depression after an acute coronary syndrome simply a marker or known prognostic factors for mortality? Psychosomatic Medicine, 71(7), 697-703.
  • Landis, J. R. y Koch, G. G. (1977). The measurement of observer agreement for categorical data. Biometrics, 33, 159-174.
  • Lichtman, J. H., Bigger Jr, J. T., Blumenthal, J. A., Frasure-Smith, N., Kaufmann, P. G., Lespérance, F., Mark, D. B., Sheps, D. S., Taylor, C. B. y Froelicher, E. S. (2008). Depression and coronary heart disease: recommendations for screening, referral, and treatment. A science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation, 118(17), 1768-1775.
  • Lichtman, J. H., Froelicher, E. S., Blumenthal, J. A., Carney, R. M., Doering, L. V., FrasureSmith, N., Freedland, K. E., Jaffe, A. S., Leifheit-Limson, E. C., Sheps, D. S., Vaccarino, V. y Wulsin, L. (2014). Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations. A scientific statement from the American Heart Association. Circulation, 129(12), 1350-1369.
  • Martens, E. J., Hoen, P. W., Mittelhaeuser, M., de Jonge, P. y Denollet, J. (2010). Symptom dimensions of post-myocardial infarction depression, disease severity and cardiac prognosis. Psychological Medicine, 40(5), 807-814.
  • Mazza, M., Lotrionte, M., Biondi-Zoccai, G., Abbate, A., Sheiban, I. y Romagnoli, E. (2010). Selective serotonin reuptake inhibitors provide significant lower re-hospitalization rates in patients recovering from acute coronary syndromes: evidence from a meta-analysis. Journal of Psychopharmacology, 24(12), 1785-1792.
  • Meijer, A., Conradi, H. J., Bos, E. H., Thombs, B. D., van Melle, J. P. y de Jonge, P. (2011). Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. General Hospital Psychiatry, 33(3), 203-216.
  • Meurs, M., Zuidersma, M., Dickens, C. y de Jonge, P. (2013). Examining the relation between post myocardial infarction depression and cardiovascular prognosis using a validated prediction model for post myocardial mortality. International Journal of Cardiology, 167(6), 2533-2538.
  • O’Neil, A., Taylor, B., Hare, D. L., Sanderson, K., Cyril, S., Venugopal, K., Chan, B., Atherton, J. J., Hawkes, A., Walters, D. L. y Oldenburg, B. (2015). Long-term efficacy of a tele-health intervention for acute coronary syndrome patients with depression: 12-month results of the MoodCare randomized controlled trial. European Journal of Preventive Cardiology, 22(9), 1111-1120.
  • O'Neil, A., Taylor, B., Sanderson, K., Cyril, S., Chan, B., Hawkes, A. L., Hare, D. L., Jelinek, M., Venugopal, K., Atherton, J. J., Amerena, J., Grigg, L., Walters, D. L., Oldenburg, B. y MoodCare investigator team (2014). Efficacy and feasibility of a tele-health intervention for acute coronary syndrome patients with depression: results of the “MoodCare” randomized controlled trial. Annals of Behavioral Medicine, 48(2), 163- 174.
  • Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., … Moher, D. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. British Medical Journal, 372, n71.
  • Pizzi, C., Rutjes, A. W. S., Costa, G. M., Fontana, F., Mezzetti, A. y Manzoli, L. (2011). Metaanalysis of selective serotonin reuptake inhibitors in patients with depression and coronary heart disease. The American Journal of Cardiology, 107(7), 972-979.
  • Rafanelli, C., Sirri, L., Grandi, S. y Fava, G. A. (2013). Is depression the wrong treatment target for improving outcome in coronary artery disease? Psychotherapy and Psychosomatics, 82(5), 285-291.
  • Raj, S. R., Stein, C. M., Saavedra, P. J. y Roden, D. M. (2009). Cardiovascular effects of noncardiovascular drugs. Circulation, 120(12), 1123-1132.
  • Reavell, J., Hopkinson, M., Clarkesmith, D. y Lane, D. A. (2018). Effectiveness of cognitive behavioral therapy for depression and anxiety in patients with cardiovascular disease: a systematic review and meta-analysis. Psychosomatic Medicine, 80(8), 742-753.
  • Ski, C. F., Jelinek, M., Jackson, A. C., Murphy, B. M. y Thompson, D. R. (2016). Psychosocial interventions for patients with coronary heart disease and depression: a systematic review and meta-analysis. European Journal of Cardiovascular Nursing, 15(5), 305- 316.
  • Smolderen, K. G., Spertus, J. A., Reid, K. J., Buchanan, D. M., Krumholz, H. M., Denollet, J., Vaccarino, V. y Chan, P. S. (2009). The association of cognitive and somatic depressive symptoms with depression recognition and outcomes after myocardial infarction. Circulation: Cardiovascular Quality and Outcomes, 2(4), 328-337.
  • Strik, J. J., Honig, A., Lousberg, R., Lousberg, A. H., Cheriex, E. C., Tuynman-Qua, H. G., Kuijpers, P. M., Wellens, H. J. J. y Van Praag, H. M. (2000). Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial. Psychosomatic Medicine, 62(6), 783-789.
  • Thombs, B. D., Bass, E. B., Ford, D. E., Stewart, K. J., Tsilidis, K. K., Patel, U., Fauerbach, J. A., Bush, D. E. y Ziegelstein, R. C. (2006). Prevalence of depression in survivors of acute myocardial infarction: review of the evidence. Journal of General Internal Medicine, 21, 30-38.
  • Thombs, B. D., de Jonge, P., Coyne, J. C., Whooley, M. A., Frasure-Smith, N., Mitchell, A. J., Zuidersma, M., Eze-Nliam, C., Lima, B. B., Smith, C.G., Soderlund, K. y Ziegelstein, R. C. (2008). Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA, 300(18), 2161-2171.
  • Thombs, B. D., Roseman, M., Coyne, J. C., de Jonge, P., Delisle, V. C., Arthurs, E., Levis, B. y Ziegelstein, R. C. (2013). Does evidence support the American Heart Association's recommendation to screen patients for depression in cardiovascular care? An updated systematic review. PloS one, 8(1), e52654.
  • Tully, P. J. y Baumeister, H. (2015). Collaborative care for comorbid depression and coronary heart disease: a systematic review and meta-analysis of randomised controlled trials. British Medical Journal open, 5(12), e009128.
  • US Preventive Services Task Force (2002). Screening for depression: recommendations and rationale. Annals of Internal Medicine, 136(10), 760-764.
  • Vaccarino, V., Badimon, L., Bremner, J. D., Cenko, E., Cubedo, J., Dorobantu, M., Duncker, D. J., Koller, A., Manfrini, O., Milicic, D., Padro, T., Pries, A. R., Quyyumi, A. A., Tousoulis, D. Trifunovic, D., Vasiljevic, Z., de Wit, C., Bugiardini, R. y ESC scientific document group reviewers (2020). Depression and coronary heart disease: 2018 position paper of the ESC working group on coronary pathophysiology and microcirculation. European Heart Journal, 41(17), 1687-1696.
  • Ye, S., Shaffer, J. A., Rieckmann, N., Schwartz, J. E., Kronish, I. M., Ladapo, J. A., Whang, W., Burg, M. M. y Davidson, K. W. (2014). Long-term outcomes of enhanced depression treatment in patients with acute coronary syndromes. The American Journal of Medicine, 127(10), 1012-1016.
Fuente de los datos: Dialnet